165 related articles for article (PubMed ID: 24750506)
21. Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: results of a feasibility study.
Cardoso F; Ferreira Filho AF; Crown J; Dolci S; Paesmans M; Riva A; Di Leo A; Piccart MJ
Anticancer Res; 2001; 21(1B):789-95. PubMed ID: 11299845
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial.
Hornsby WE; Douglas PS; West MJ; Kenjale AA; Lane AR; Schwitzer ER; Ray KA; Herndon JE; Coan A; Gutierrez A; Hornsby KP; Hamilton E; Wilke LG; Kimmick GG; Peppercorn JM; Jones LW
Acta Oncol; 2014 Jan; 53(1):65-74. PubMed ID: 23957716
[TBL] [Abstract][Full Text] [Related]
23. Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study.
DeNysschen CA; Burton H; Ademuyiwa F; Levine E; Tetewsky S; O'Connor T
Eur J Cancer Care (Engl); 2014 Jul; 23(4):493-501. PubMed ID: 24289215
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer.
Pietri E; Andreis D; Fabbri F; Menna C; Schirone A; Kopf B; Rocca A; Amadori D; De Giorgi U
Oncologist; 2015 Mar; 20(3):239-40. PubMed ID: 25637379
[TBL] [Abstract][Full Text] [Related]
25. Acute and late toxicity following adjuvant high-dose chemotherapy for high-risk primary operable breast cancer--a quality assessment study.
Svane IM; Homburg KM; Kamby C; Nielsen DL; Roer O; Sliffsgaard D; Johnsen HE; Hansen SW
Acta Oncol; 2002; 41(7-8):675-83. PubMed ID: 14651213
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
[TBL] [Abstract][Full Text] [Related]
27. A survey of joint and muscle aches, pain, and stiffness comparing women with and without breast cancer.
Fenlon D; Addington-Hall JM; O'Callaghan AC; Clough J; Nicholls P; Simmonds P
J Pain Symptom Manage; 2013 Oct; 46(4):523-35. PubMed ID: 23507130
[TBL] [Abstract][Full Text] [Related]
28. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.
Courneya KS; Segal RJ; Mackey JR; Gelmon K; Reid RD; Friedenreich CM; Ladha AB; Proulx C; Vallance JK; Lane K; Yasui Y; McKenzie DC
J Clin Oncol; 2007 Oct; 25(28):4396-404. PubMed ID: 17785708
[TBL] [Abstract][Full Text] [Related]
29. The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer.
Headley JA; Ownby KK; John LD
Oncol Nurs Forum; 2004 Sep; 31(5):977-83. PubMed ID: 15378098
[TBL] [Abstract][Full Text] [Related]
30. Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation.
Haines TP; Sinnamon P; Wetzig NG; Lehman M; Walpole E; Pratt T; Smith A
Breast Cancer Res Treat; 2010 Nov; 124(1):163-75. PubMed ID: 20734132
[TBL] [Abstract][Full Text] [Related]
31. Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04).
Takei H; Ohsumi S; Shimozuma K; Takehara M; Suemasu K; Ohashi Y; Hozumi Y
Breast Cancer Res Treat; 2012 May; 133(1):227-36. PubMed ID: 22234519
[TBL] [Abstract][Full Text] [Related]
32. [Neoadjuvant chemotherapy with docetaxel plus epirubicin for locally advanced breast cancer: a multi-center phase II study].
Shen ZZ; Liu GY; Su FX; He PQ; Yang MT; Shi JY; Sheng Y; Zou Q; Li YF
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):126-8. PubMed ID: 15946557
[TBL] [Abstract][Full Text] [Related]
33. The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy.
Adamsen L; Quist M; Midtgaard J; Andersen C; Møller T; Knutsen L; Tveterås A; Rorth M
Support Care Cancer; 2006 Feb; 14(2):116-27. PubMed ID: 16096771
[TBL] [Abstract][Full Text] [Related]
34. High-intensity resistance and cardiovascular training improve physical capacity in cancer patients undergoing chemotherapy.
Quist M; Rorth M; Zacho M; Andersen C; Moeller T; Midtgaard J; Adamsen L
Scand J Med Sci Sports; 2006 Oct; 16(5):349-57. PubMed ID: 16978255
[TBL] [Abstract][Full Text] [Related]
35. FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG).
Polyzos A; Malamos N; Boukovinas I; Adamou A; Ziras N; Kalbakis K; Kakolyris S; Syrigos K; Papakotoulas P; Kouroussis C; Karvounis N; Vamvakas L; Christophyllakis C; Athanasiadis A; Varthalitis I; Georgoulias V; Mavroudis D
Breast Cancer Res Treat; 2010 Jan; 119(1):95-104. PubMed ID: 19636702
[TBL] [Abstract][Full Text] [Related]
36. Resistance Exercise and Inflammation in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy: Mediation Analysis From a Randomized, Controlled Intervention Trial.
Schmidt ME; Meynköhn A; Habermann N; Wiskemann J; Oelmann J; Hof H; Wessels S; Klassen O; Debus J; Potthoff K; Steindorf K; Ulrich CM
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):329-37. PubMed ID: 26853341
[TBL] [Abstract][Full Text] [Related]
37. High pathologic complete response in HER 2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin.
Chen SC; Chang HK; Lin YC; Hsueh S; Cheung YC; Leung WM; Tsai CS; Lo YF; Tsai HP; Shen SC; Chen MF
Jpn J Clin Oncol; 2008 Feb; 38(2):99-105. PubMed ID: 18270380
[TBL] [Abstract][Full Text] [Related]
38. Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer.
Ligibel JA; Partridge A; Giobbie-Hurder A; Campbell N; Shockro L; Salinardi T; Winer EP
J Womens Health (Larchmt); 2010 Aug; 19(8):1553-9. PubMed ID: 20629579
[TBL] [Abstract][Full Text] [Related]
39. Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy.
van Vulpen JK; Schmidt ME; Velthuis MJ; Wiskemann J; Schneeweiss A; Vermeulen RCH; Habermann N; Ulrich CM; Peeters PHM; van der Wall E; May AM; Steindorf K
Breast Cancer Res Treat; 2018 Apr; 168(2):421-431. PubMed ID: 29235043
[TBL] [Abstract][Full Text] [Related]
40. Transforming the nature of fatigue through exercise: qualitative findings from a multidimensional exercise programme in cancer patients undergoing chemotherapy.
Adamsen L; Midtgaard J; Andersen C; Quist M; Moeller T; Roerth M
Eur J Cancer Care (Engl); 2004 Sep; 13(4):362-70. PubMed ID: 15305905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
